Skip to content
Home
menu
  • Home
  • News
  • Clinical Research
  • Scientific Publications
    • White Papers
    • Clinical Science Compendia
    • Abstract Books
    • Perspectives On Vision
    • Science and Technology Articles
  • Educational Videos
    • Educational Videos
    • Technology and Clinical Insights Videos
    • Clinical Research Summary Videos
  • Contact Us
  • Medical Education
    • Medical Education
    • Independent Medical Education
      • Goals and Initiatives
      • Grant Process
      • Policies and Guidelines
    • Resident Education Equipment
    • Post Graduate Specialized Grant
    • Contact Medical Education

Contribution of a 3-D Heads-up Visualization System (NGENUITY®) to Significantly Decreased Light Intensity During Ophthalmic Surgeries

By Alcon
July 15, 2021
Peer-Reviewed Manuscripts
Like 4267
0

A recent publication found in Journal Français d'Ophtalmologie addresses the ability of digital visualization systems, specifically, the NGENUITY®3D Visualization System, to reduce the required light intensity for both anterior and posterior ophthalmic surgeries when compared to the light intensity routinely used with conventional systems (80% for both cataract and vitreoretinal surgeries).†

This single center, post-learning curve observational study consisted of 142 consecutive initial eye surgeries (73 cataract surgeries and 69 vitreoretinal surgeries) performed between November 2018 and January 2019.  Patient demographics, ocular characteristics, surgical time and microscope or endoillumination light intensity levels (the primary endpoint) were collected. Light intensity percentage values were converted into corresponding output in lumens (lm).†

Using NGENUITY®:

  • The mean delivered light intensity in cataract surgeries was significantly lower than the theoretical reference of 80% down to 15% (decrease from 2.5 to 0.3 lm; p < 0.0001)†
  • The light intensity for vitreoretinal surgeries was also reduced by a factor of about 3 from the theoretical 80% down to 27.8% (decrease from 4.3 to 1.5 lm; p < 0.0001)†
  • For combined vitreoretinal and cataract surgeries, the light intensity decreased from the theoretical 80% down to 21.2%†
  • There were no intraoperative complications observed and no adverse events attributed to the visualization system†

Please see the PubMed link to the article, below:

† Vélasque L, Arbousoff N, Rigaudier F, Dominguez M, Fourmaux E, Rosier L, Seguy C. Lux study: Contribution of a three-dimensional, high dynamic range, ultra-high-definition heads-up visualization system to a significant delivered light intensity decrease during different types of ocular surgeries. J Fr Ophtalmol. 2021 Jul 7:S0181-5512(21)00309-0.

PubMed link: https://pubmed.ncbi.nlm.nih.gov/34246497/

 

 

 

IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to sale by, or on the order of, a physician.

INDICATION: The NGENUITY® 3D Visualization System consists of a 3D stereoscopic, high-definition digital video camera and workstation to provide magnified stereoscopic images of objects during micro-surgery. It acts as an adjunct to the surgical microscope during surgery displaying real-time images or images from recordings.

WARNINGS: The system is not suitable for use in the presence of flammable anesthetics mixture with air or oxygen. There are no known contraindications for use of this device.

PRECAUTIONS: Do not touch any system component and the patient at the same time during a procedure to prevent electric shock. When operating in 3D, to ensure optimal image quality, use only approved passive-polarized glasses. Use of polarized prescription glasses will cause the 3D effect to be distorted. In case of emergency, keep the microscope oculars and mounting accessories in the cart top drawer. If there are any concerns regarding the continued safe use of the NGENUITY® 3D Visualization System, consider returning to using the microscope oculars.

ATTENTION: Refer to the User Manual for a complete list of appropriate uses, warnings and precautions.

 

© 2021 Alcon Inc.      07/21      US-NGU-2100055

 

You are on a website for Health Care Professionals in the United States

By clicking below “OK” you acknowledge that this site is intended for Health Care professionals only
OK Other country
Alcon-Header-1-900x600
Next Post

Customized NGENUITY Color Settings Enable Use of Lower Dye Concentration in Macular Surgery

Customized NGENUITY Color Settings Enable Use of Lower Dye Concentration in Macular Surgery
  • United States
Questions for Alcon Medical Affairs?
Contact Us

News

Clinical Research

Scientific Publications

Educational Videos

Medical Education

Contact Us

MyAlcon

Terms of Use Privacy Policy About Cookies California resident? Do Not Sell My Personal Information
  • United States
Terms of Use Privacy Policy About Cookies California resident? Do Not Sell My Personal Information